开设账户
模拟账户
关于我们
即时报价及新闻
市场分析
财经日历
每日市场分析
交易平台
下载及介绍
使用教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
繁
简
EN
客户登入
开设账户
模拟账户
繁
简
EN
客户登入
开设账户
模拟账户
关于我们
上志国际介绍
上志国际优势
即时报价及新闻
即时报价
即时新闻
市场分析
财经日历
市场分析
交易平台
平台特点
平台教学
交易细则
各项细则
资金提存
推广和资讯
常见问题
联络我们
关于我们
交易细则
贵金属市场
交易平台
市场分析
推广和资讯
常见问题
联络我们
繁
简
EN
Malaysian ringgit fell 0.4% against the dollar to 4.152 per dollar, its weakest level since Nov. 24, 2025.
2026-06-22
Malaysian ringgit fell 0.4% against the dollar to 4.152 per dollar, its weakest level since Nov. 24, 2025.
返回
其他消息
2026-06-21
On June 20, multiple Xiaomi Auto front‑line sales staff said dealerships have launched an employee internal‑purchase program allowing ordinary consumers who use employee channels to buy certain in‑stock vehicles at a CNY10,000 discount. Affected models include SU7 Pro and YU7 long‑range, Pro and Max variants; for example, a YU7 long‑range with optional equipment listed at CNY260,500 on the official app is available via the internal channel for CNY250,500.
On June 20, multiple Xiaomi Auto front‑line sales staff said dealerships have launched an employee internal‑purchase program allowing ordinary consumers who use employee channels to buy certain in‑stock vehicles at a CNY10,000 discount. Affected models include SU7 Pro and YU7 long‑range, Pro and Max variants; for example, a YU7 long‑range with optional equipment listed at CNY260,500 on the official app is available via the internal channel for CNY250,500.
2026-06-22
The National Medical Products Administration (NMPA) today released its 2025 Annual Report on New Drug Registration Clinical Trial Progress, showing China’s total number of drug clinical trials surpassed 5,000 for the first time. The report says 248 new drugs received regulatory approval following clinical trials in 2025, covering 18 indication areas including oncology, endocrine and psychiatric disorders.
The National Medical Products Administration (NMPA) today released its 2025 Annual Report on New Drug Registration Clinical Trial Progress, showing China’s total number of drug clinical trials surpassed 5,000 for the first time. The report says 248 new drugs received regulatory approval following clinical trials in 2025, covering 18 indication areas including oncology, endocrine and psychiatric disorders.
Chat with us
, powered by
LiveChat